PMC:7029158 / 2604-2820
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T2 | 142-145 | Body_part | denotes | HIV | http://purl.org/sig/ont/fma/fma278683 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T10 | 146-150 | Disease | denotes | AIDS | http://purl.obolibrary.org/obo/MONDO_0012268 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T3 | 16-21 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
T4 | 48-67 | Chemical | denotes | protease inhibitors | http://purl.obolibrary.org/obo/CHEBI_37670|http://purl.obolibrary.org/obo/CHEBI_60258 |
T6 | 57-67 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
T7 | 79-88 | Chemical | denotes | Lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T16 | 0-216 | Sentence | denotes | Anti-retroviral drugs belonging to the class of protease inhibitors, including Lopinavir and Ritonavir, usually utilized for the treatment of HIV/AIDS patients, seem to exert anti-viral effects against coronaviruses. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
45 | 151-159 | Species | denotes | patients | Tax:9606 |
46 | 202-215 | Species | denotes | coronaviruses | Tax:11118 |
50 | 79-88 | Chemical | denotes | Lopinavir | MESH:D061466 |
56 | 142-145 | Disease | denotes | HIV | MESH:D015658 |
57 | 146-150 | Disease | denotes | AIDS | MESH:D000163 |